Wellington Management Company’s Challenging Bristol-Myers Squibb Takeover of Celgene Corporation

Schulte advised Wellington Management Company in challenging the planned $74-billion takeover of global biopharmaceutical company Celgene Corporation by Bristol-Myers Squibb, in which Wellington Management is a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now